The signals that determine the size and duration of the primary T cell immune response are not well defined. We studied CD4 T cells at an important checkpoint in their development: when they have become effectors and are ready to rapidly mediate effector functions, both via direct interaction with antigen (Ag)-presenting cells and via cytokine production. We determined the effects of specific Ag and the cytokines interleukin (IL) 2 and transforming growth factor (TGF) 81 on T helper call type 2 (Th2) effector apoptosis versus expansion. Th2-polarized effector calls were generated in vitro from naive CD4 T of T cell receptor transgenic mice, and then restimulated with or without peptide Ag plus Ag-presenting cells and cytokines. In the absence of added cytokines, effector cells cultured without Ag died of apoptosis after 4-7 d. Paradoxically, Ag both induced proliferation and high levels of cytokine synthesis and accelerated effector cell death. IL-2 directly induced proliferation of effectors, supported and prolonged Aginduced proliferation, and partially blocked apoptosis. TGF-B did not effect proliferation or influence cytokine secretion, but it also partially blocked apoptosis. Together, IL-2 and TGF-/3 synergized to almost completely block apoptosis, resulting in prolonged effector expansion and leading to the accumulation of a large pool of specific effectors. When Ag and both cytokines were present, the effector population increased 104-10S-fold over 20 d of culture. The synergy of Ib2 and TGF-fl suggests that they interfere with programmed call death by distinct mechanisms. Since Th2 effectors are specialized to help B cells develop into antibody-secreting plasma ceils, these results suggest that the availability of Ag and of the cytokines IL-2 and TGF-~ is a key factor influencing the fate of Th2 effector cells and thus the size and duration of the primary antibody response.
T he response of lymphocytes to external stimuli can include activation of cytokine production, proliferation, differentiation, and expansion or death by apoptosis (for review see references I and 2). Lymphocytes at different stages of development respond differentially to Ag stimulation. For example, as developing T cells express specific TCR in the thymus, they change from rapidly proliferating cells to small resting cells that express a default program for apoptosis unless they undergo positive selection (3) . These same T cells are susceptible to activation-induced cell death (AICD) 1 if they recognize Ag with high avidity (negative selection) (4) . In contrast, mature naive T cells persist for several weeks in situ without Ag stimulation (5, 6) . Appropriate Ag stimu-1 Abbreviations used in this paper: AICD, activation-induced cell death; FL, fluoresceinated; mit C, mitomycin C; PCCF, pigeon cytochrome C fragment; PI, propidium iodide; Tg, tramgenic; TdT, terminal deoxynucleotidyl transferase.
lation results in Ib2 production, proliferation, and development of effector T ceils (5, 7) . The frequency of naive T cells able to recognize any particular protein Ag is -1 in 104-106 (8) . Thus, a protective response requires substantial expansion of a few specific cells to generate a large population of effector cells. After infection with a replicating organism, the effector population must be large enough to deal with a large pathogen load. On the other hand, once the Ag/organism has been cleared, the effectors are no longer needed and are taking up valuable space in the immune system, and, because of their potent effector functions and low activation requirements (9), they are potentially dangerous. Effector responses in vivo (5-7) are often transient, and effectors have a short life span in vitro (10) . Indeed, responses to some viruses are accompanied by high rates of T cell apoptosis (11) and "exhaustion" of the immune response (12) . In other studies, however, high numbers of effectors have been generated, and effector responses were found to be prolonged (13) .
The AICD of activated normal T cells or T cell lines has been described in many recent reports (14) (15) (16) (17) (18) (19) . It has been suggested that II-2 and high Ag dose play key roles in inducing apoptosis, and that this is responsible for the termination of effector responses and also perhaps for tolerance seen at high Ag dose (18) . Most of these reports have used Thl-polarized populations, which secrete II.-2, IFN-7, and TNF-ce. The conditions favoring the expansion of effector populations are less well defined and have not been extensively studied. Experience in the generation of T cell lines and clones indicates that II,2 and occasional Ag stimulation are required for the maintenance of both Thl and Th2 lines (for review see references 20 and 21). I1,2 plays a central role in T cell response, acting as the major product of naive CD4 T, which can provide autocrine growth of responding cells. In many T cell responses, the degree of T cell expansion is proportional to the amount of I1,2 available, and I1,2 deprivation leads to apoptosis (19, 22) .
TGF-B1 (and other TGF-B family members) have a large number of pleiotropic effects on T cells (for review see reference 23). Most studies have stressed its growth-inhibitory effects (23) (24) (25) , but we found TGF-/3 to have long-term growth-promoting effects when it was added to naive CD4 (26) , and addition of TGF-~ to effector generation cultures resulted in effectors that secreted higher titers of I1,2 and expressed a distinct phenotype more like that of memory cells. TGF-B also increased cell proliferation and IFN-7 production in CD8 cells (27) .
To investigate the factors that regulate expansion of Th2 effectors, we designed experiments to analyze the roles of Ag, Ib2, and TGF-/~ in effector cell recovery, proliferation, and apoptosis. Effector T cells are activated cells, ready to quickly mediate effector function upon restimulation without further differentiation (5, 8) . They express high levels of adhesion and costimulatory receptors (5, 28) , and they synthesize and secrete cytokines within a few hours of stimulation (29) . This contrasts to resting naive and memory T lymphocytes, which require several days of proliferation and/or differentiation before they attain optimal functionality (8, 10) . We generate Th2 effectors in short-term in vitro cultures from isolated, naive CD4 T cells ofTCR transgenic mice (Tg) (28) , allowing us to use a defined Ag (a pigeon cytochrome C peptide [PCCF]) to study Ag effects in a well-defined, recently ex vivo model. We focus here on Th2 effectors that produce high levels of I1,4 and I1,5 but little I1,2 (28), allowing uncomplicated analysis of I1,2 effects. Th2 effectors carry out unique functions in immune response, promoting B cell differentiation and IgG1, IgA, and IgE Ab production (9) . Moreover, the fate of Th2 effectors has received little attention.
We report that, in the absence of added cytokines, effectors undergo apoptosis after several days of culture, but that Ag stimulation accelerates their death. However, I1-2 and TGF-~ synergize to dramatically block apoptosis and sustain an impressive expansion of the population. These studies identify the effector stage as a key checkpoint at which the immune response can be either terminated or prolonged and expanded, and which might be amenable to therapeutic intervention.
Materials and Methods
Mice. H-2 b/k or H-2 k/k Vf3/Voe11 and TCR Tg mice (28) were bred in the animal facilities at the University of California, San Diego, and used at 3-6 mo of age.
Reagents. Medium for all in vitro cultures was complete RPMI 1640 supplemented with penidllin (200/~g/liter), streptomycin (200 /~g/liter), and glutamine (4/~M) plus 10% selected FCS from Hyclone Laboratories (Logan, UT). PCCF 88-104, used as Ag in all experiments, was synthesized by the peptide synthesis facility at the University of California, San Diego, and purified by HPLC.
Cytokines. Recombinant IL-2 (human, 10-20 U/ml from the Biological Response Modifiers Program, National Institutes of Health, Bethesda, MD) or murine II.-2 (derived from the X63-Ib2 line transfected with the murine I1.-2 gene [30] ) were used interchangeably and had equivalent effects. Porcine TGF-fll (referred to as TGF-fll throughout) was purchased from IL&D Systems (Minneapolis, MN). Control cytokines used to standardize cytokine assays IL-2, Ib4, and Ib5 were purified from the X63.Ag8-653 lines transfected with the murine cytokine genes (30) . Recombinant murine IFN-7 was obtained from Genzyme Corp. (Cambridge, MA).
Cell Preparations. Purified naive CD4 + T cells from Tg mice were isolated as described previously (28) . Spleen cells were passed over nylon columns to remove B, adherent, and activated cells, and then treated with anti-CD8 and anti-HSA (J11D) plus C'. Cells were >90% CD4 + resting cells with naive phenotype (28, 31) . APC for effector generation were prepared by T cell depletion of spleen cells with 2 anti-Thy 1.2 Ab (F7D5 and HO13.14), anti-CD4 (RL172.4), and anti-CD8 (HO2.2 and AD4) plus C' and treatment with 50/~g/ml of mitomycin C (mit C). For restimulation of effectors, mit C-treated cells of DCEK-ICAM, a fibroblast line transfected with I-E k and ICAM-1 (32), which expresses high levels of B7.1 (Dubey, C., M. Croft, and S. L. Swain, unpublished observations), was used.
CD4 effectors were generated as previously reported (28) . Purified T cells (3 x 10S/ml) were cultured with APC and PCCF plus 20 U/ml Ib2. Ib4 (200 U/ml) plus 10 #g/ml anti-IFN-7 was added at the start of culture to generate Th2 effectors. Effectors were harvested, counted, and washed after 4-5 d, and then recultured at 5 x 10S/ml viable CD4 § cells with either 1.7 x 10S/ml of APC plus 5 #M of PCCF (Ag/APC) or APC alone. Additions of I1.-2 (20 U/ml), TGF-B (1 ng/ml), or IL-2 plus TGF-B were made to aliquots of the second cultures. Cells in flasks (T75; Falcon Labware, Oxnard, CA) were split if they became concentrated. According to the design of the experiment, recultured effector cells were harvested at different days, counted, and further analyzed. Cell C~cle Analysis. Cells were stained with FL-anti-CD4, fixed in 60% ethanol, washed, and incubated with 10 U/ml RNase A and 2 #g/m1 propidium iodide (PI) as described by Nicoletti et al. (34) . The programs MULTICYCLE and MCYCLE (Phoenix Flow Systems, San Diego, CA) were used for analysis.
DNA Fragmentation
Cytokine Analysis. Titers of IL-2, IL-4, IL-5, and IFN-7 were determined from supernatants collected 18-24 h after restimulation of effector cells as described previously (7).
Cell Recovery and Proliferation. Effectors were harvested either after the generation culture (day 4) or after further reculture. Experimental Design. All experiments had the same basic design. Th2 effectors were generated in vitro, harvested, and divided into groups for reculture. Aliquots were restimulated with APC, with or without PCCF, with either: no cytokine, Ib2 alone, TGF-fl alone, or both. Recovered cells were analyzed at different times after restimulation as indicated. Tg CD4 cells are almost all naive (31), and after 4-5 d of stimulation they develop into a population of effectors (as judged by their functional activities and phenotype) (28) . This first culture routinely results in a 10-fold increase in cells under standard conditions (Ib2 added at 20 U/ml) (see Fig. 1 ) and a much larger increase in the per-call capacity for the secretion of IL-4 (28). The mit C-treated APC used to generate effectors disappear by the end of culture. The APC used to restimulate the effectors also disappear rapidly, constituting <5% of recovered cells at 24 h and <1-3% thereafter (not shown). We focus here on Th2 effectors by adding Ib4 (plus anti-IFN-'y) to the generation cultures, which results in effectors polarized for Th2 cytokine production (10, 28 , and see Figs. 6 and 7). The effectors were routinely analyzed by staining and were invariably CD4 +, Tg TCR + cells with an activated phenotype including high expression of CD44, CD45RB, and IL-2R (28) . Fig. 2, top) with those stimulated with APC alone (Fig. 2, bottom) . Cells at each of these time points were >95% CD4 § cells.
Effect of Ag Stimulation and Cytokines 11.,2 and TC, F-B on
DNA from fresh, naive cells and from freshly isolated effectors was largely intact. DNA of recultured effectors without Ag or cytokines (Fig. 2, bottom) PCCF-stimulated cells with no cytokines showed marked DNA ladders by 2 d of culture, which peaked at day 4 and continued to be prominent at day 7 (Fig. 2, top) . Thus, Ag stimulation accelerated the rate of cell death. It should be noted that, in repeat experiments, maximum DNA fragmentation in Ag-stimulated cultures occurred slighdy later, around day 4 (see Fig. 3 ), suggesting that Th2 effector cells undergo quite delayed apoptosis, even after stimulation with Ag. The level of Ag used here for restimulation (5/~M) is a level that stimulates optimum proliferation and cytokine secretion from both naive and effector CD4 T, but similar levels of apoptosis were seen at 10-fold lower and higher levels of PCCF (see Fig. 6 ).
In cultures with or without Ag, addition of I1:2 led to decreased DNA laddering at days 4 and 7. Addition of TGF-3 decreased fragmentation early but on its own had little effect later. TGF-B is a ubiquitously produced cytokine, so we also tested whether Ab to it would block the effect of I1:2. A slight enhancement of laddering was seen only at 7 d in cultures both with and without Ag. Dramatically, addition of TGF-B with I1:2 was able to prevent all detectable fragmentation in Ag-stimulated as well as in no Ag effectors. In further studies we have concentrated on the effects of cytokines on PCCF-stimulated effectors, because the effects are more dramatic, but the effects of II.-2 and TGF-B in blocking apoptosis are also consistently seen when no Ag is present.
To better quantitate the DNA changes associated with apoptosis, we used the TdT UTP nick-end labeling method to visualize nicks in the DNA. Permeabilized cells were treated with TdT plus biotinylated dUTP followed by FL-avidin, allowing an assessment of the percentage of stained, apoptotic cells. Groups of restimulated Th2 effector populations were analyzed 2, 4, and 7 d after reculture with Ag. TdT staining of CD4 +-gated cells is shown in Fig. 3 
Kinetics of Cytokine Effects on Cell Cycle Progression and Proliferation. To analyze possible mechanisms involved in Ig2 and
TGF-~ effects, we analyzed the kinetics of DNA synthesis and cell cycle progression of Ag-restimulated Th2 effectors. Effectors were harvested after 0, 1, 2, and 4 d and stained with PI, and the proportion of cells in G0/G1, S, G2, and M was determined. Fig. 4 (left) shows the total fraction of cycling effectors. The distribution of cells in each of the phases of cycle was proportional in each group (not shown). Before restimulation, approximately one-third of the cells were actively cycling (day 0), compared with <5% among naive CD4 T (not shown). Ag stimulation led to a large increase in the 703 Zhang et al.
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DNA Strand Breaks Associated with Apoptosis In some models, TGF-B has been shown to cause cell cycle arrest, especially in G1, and suppression of cell growth (35) (36) (37) . In this case, TGF-~ did not cause cell cycle arrest in G1, nor did it slow cell cycle progression. DNA synthesis, commonly used as an indicator of"prolfferation,' was analyzed in cultures ofeffectors restimulated with (Fig. 4, middle) or without (Fig. 4, right) PCCE With Ag, effectors incorporated/adiolabel with or without cytokines at days 1 and 2 (presumably responding to the I1.-4 they secrete), but the I1:2-supplemented groups had prolonged synthesis of DNA. Effectors in cultures without PCCF (which produced no endogenous cytokine) synthesized little DNA (Fig. 4 C) . I1:2, but not TGF-B, directly supported DNA synthesis of non-Ag-stimulated cells. Thus, TGF-fl did not directly promote growth of the Th2 effectors, but it prolonged I1:2-supported proliferation. Radiolabel was added during day 1, day 2, or day 4 of culture, and incorporation was determined after 18 h. some cases, high doses of II.-2 have been found to promote rather than inhibit apoptosis (17, 18), so we investigated the effects of IL-2 dose ( 
11-,2 and TC, tZ~ Synergize over a Broad Range of Doses. In Cell Cycle Progression

Effect of Ag Dose on Effector Fate. Since high Ag dose has
been suggested to favor activated T cell apoptosis (18), we compared the effect of PCCF dose on apoptosis, Ib4 production, and DNA synthesis, each measured 2 d after restimulation. Results are shown in Fig. 6 . TdT staining, II-4 production, and DNA synthesis each increased with Ag dose, becoming maximum in the range of 1-10 pM PCCF. Thus, induction of each of these responses occurred at comparable Ag doses. 
Effects of lL2 and TGF-I~ on
Prolonged Effects of TGF-I~ Treatment on Long-term Effector
Expansion. Since IL-2 and TGF-/3 together effectively block apoptosis, and since IL-2 sustains proliferation of activated T cells, we reasoned that effector cells periodically restimulated with Ag, Ib2, and TGF-/~ might be able to undergo many rounds of proliferation. To test this prediction, Th2 effectors were generated, harvested, and counted after 6 d and with the number of naive CD4 T cultured at day 0. Without TGF-B, total expansion was severalfold less. In other experiments, it was found that the addition of TGF-3 at least one more time late in culture gave additional increases in CD4 effector recovery (not shown). At all time points the effector populations made impressive amounts of appropriate cytokines when restimulated with Ag/APC (not shown). It was particularly striking that the effects of TGF-3 added only at day 6 were still detectable 2 wk later. Figure 8 . Effect of cytokines on long-term effector expansion. Th2 effectors were generated. After 6 d, 5 x 10S/ml effector cells were recultured with PCCF plus APC in the presence of 20 U/ml of Ib2 (A) or Ib2 plus 1 ng/ml of TGF-~ (A). TGF-B was added only at day 6. Ib2 was added periodically when fresh medium was used. Cells were counted at 12 and 14 d. Aliquots of harvested cells were restimulated by PCCF plus APC at day 14, and cells were harvested again after a total culture of 20 d. Cell recovery, calculated by determining the number of CD4 projected if all effectors were recultured on clay 14, was compared with the number of naive cells to calculate effector expansion over the entire culture period.
Discussion
The mechanisms underlying expansion and contraction of Ag-specific lymphocytes during immune response and the conditions that regulate the denouement or prolongation of the response have received far less attention than those factors that promote its initiation. Results from the experiments in this paper suggest that the effector stage is an important checkpoint for regulation of the size and duration of the primary response of CD4 T cells, and that the Th2 effector population can either be programmed or induced to die of apoptosis or can expand up to 1,000-fold over the next 2 wk. The experiments dearly identify several factors that regulate these fates of CD4 effector cells, including: (a) Ag stimulation, which promotes proliferation, cytokine production, and apoptosis, with the outcome of its effects depending on the presence of other factors; (b) IL-2, which supports expansion and also participates in blocking apoptotic death; and (c) TGF-fl, which synergizes with II.-2 to block apoptosis and promote effector expansion, but which does not act as a growth factor. Thus, it appears that the array of signals that impinge on recently generated effector cells will determine whether the Th2 response is terminated or prolonged and increased, and that this stage of an immune response may be one at which therapeutic intervention is particularly relevant. While recent studies have focused on the conditions favoring exhaustion of effector responses by induction of apoptosis (14) (15) (16) (17) (18) (19) , the current study supports the concept that conditions can also be found that favor the opposite outcome of expanded response.
Ag-specific, Th2-polarized effectors generated in vitro from naive CD4 cells of TCR Tg mice were used to examine the consequences of restimulation with Ag, IL-2, and TGF-fl. Effectors carry out their functions of cytokine production and helper function rapidly after restimulation (10, 29) and are easily detected after primary Ag injection in vivo as well as in vitro (7), attesting to their physiological relevance. Transfer of identical populations to adoptive hosts results in the development of long-term CD4 memory, indicating their potential for further development (28) . Here we monitored the kinetics of effector expansion, cytokine production, DNA synthesis, cell cycle progression, and apoptotic death.
Ag stimulation induced each response, including production of high titers of specific cytokine by 24 h (Figs. 6 and 7; 28), entry into cell cycle and DNA synthesis (Fig. 4 ) within 1 d, and a delayed apoptosis (AICD), which commenced after the burst of cytokine production at 2-4 d (Figs. 1 and 2) . Thus, in the absence of interfering cytokines, restimulated effectors synthesized and secreted cytokines and underwent cell division but did not expand in number (Fig. 1) , because a majority of the population was dead or dying by 4 d. It is likely that TCR triggering induced expression of components of an apoptotic pathway, a result reported previously for bulk-activated T cells and Thl lines (14) (15) (16) (17) . The AICD ofTh2 effectors is considerably slower than that reported for cell lines or hybridomas (38) . The dose of Ag optimal for each of these was comparable (Fig. 6 ), supporting a model in which common signal transduction events are shared by the different pathways (38) . Critchfield et al., reported that apoptosis in Thl clones and recently activated CD4 T ceils was most evident at high Ag dose (18) . These results suggest a paradigm in which effectors reencountering Ag but not receiving additional signals will carry out their effector functions and then die of apoptosis. This phenomenon is liable to be largely responsible for the apparent exhaustion of responses to viruses that remain present at high titers (12) and also to cases of high dose tolerance, as described by Lenardo and co-workers (18) . It can also be postulated that this kind of mechanism of exhaustion of responses to persisting Ag may be an important component of protection against autoimmunity.
Interestingly, effectors not exposed to Ag survived several days and only then began to die of apoptosis, causing the loss of the effector population after 4-8 d of culture (Fig.  1) . This in vitro data parands the kinetics of an in vivo response to a soluble protein such as KLH, which shows a sharp peak of effector function at days 4-7, with a decline after that to baseline levels by day 14 (8) . Thus, in the absence of Ag or other mitigating factors, the effector population is short lived and the response is transient. This kind of phenomenon would provide a natural termination of the effector respon.~e once the response had succeeded in dealing the organism or Ag that initially induced it.
The most novel finding is that TGF-~ and ID2 can synergize to prevent the apoptotic death (Figs. 2 and 3 ) of Th2 effectors, leading to prolonged expansion of the effector population ( Figs. 1 and 8) . Both Ib2 and TGF-~ alone were able to partially block apoptosis. I1.-2 is the major growth factor for T cells, directly supporting cell cycle progression in activated T cells expressing II.,2R (20) such as effectors. Activated lymphocytes are often addicted to growth factors, sufering apoptotic death when they are withdrawn (for review see references 19 and 39 ). This appears to be the case for activated T cells, which, in a number of models, die unless Ib2 is provided (22) , and it is seen here for Th2 effectors. Prolonged, dramatic expansion of Thl effectors was also seen under the same conditions (not shown).
Recent studies of Critchfield et al. described a facilitating effect of II.-2 in the apoptosis of in vitro activated CD4 T cells and Thl clones (18) . They found that the degree of apoptosis was correlated with the amount Ib2 during the first stage of culture and restimulation and that Ib2 was necessary for the apoptosis of a Thl done. Those results are in apparent contrast to the results reported here for Th2 effectors. We observed that Ib2, as expected, directly induced DNA synthesis of effectors, and enhanced cell cycle progression (Fig.  4) , but here it led to a decrease in DNA laddering in both Ag-stimulated and unstimulated effectors (Fig. 2) , as well as a decrease in the proportion of cells with damaged, nicked DNA (Fig. 3) . At no concentration we tested, from 0.6 to 600 U/ml of 1I.,2, did the addition of II.-2 increase apoptosis (Fig. 5 ). Presumably as a consequenceof these effects, Ib2, when present continuously, supported impressive expansion of effectors (Figs. 1 and 8) . Several factors could explain the apparent differences between that report and the results here.
First, we have used Th2, not Thl-like cells, and there could be differences between the two subsets. Indeed, we have noted some differences between Thl and Th2 effectors within the first few days after restimulation (Zhang, X., and S. L. Swain, unpublished observations). Second, we have analyzed expansion over a longer time frame. Further experiments will be needed to determine which of these factors accounts for the difference in results. We are currently exploring whether Thl effectors behave more like the Thl lines and undergo rapid, Ib2-dependent apoptosis.
In some models, apoptosis occurs preferentially during a particular phase of cell cycle such as G1 (35, 36) , G2 (39), or S (40), although others report no such dependence (15, 19) . IL-2 did not seem to protect effectors merely by driving them through cell cycle, since Ag stimulation, which was as efficient in driving cell cycle progression and DNA synthesis (Fig. 4) , resulted in high levels of apoptosis. Moreover, the addition of IL-4, which also supports proliferation, did not block apoptosis (Zhang, X., and S. L. Swain, unpublished observations), and the stimulated Th2 effectors made abundant Ib4 (Fig. 6) .
Particularly striking is the unexpected ability of TGF-B to block apoptosis. TGF-~ is a highly pleiotropic cytokine with multiple positive and negative effects on growth and differentiation of a wide range of cell types. The TGF-B family and other related cytokines are noted for their effects on cell differentiation (41, 42) . In the immune system it is best known for its negative effects on T and B cell proliferation (23) (24) (25) and its ability to drive B cells to switch to the IgA isotype oflg (43) . TGF-B has even been reported to induce apoptosis of some kinds of cells (44, 45) . The effects of TGF-~ thus seem to differ with the cell type and/or the stage of differentiation, and it has been suggested that it acts as a kind of switch to change whatever pattern of differentiation is currently in place (25) . We found earlier that TGF-B had a series of interesting effects when it was added during effector generation. Addition of TGF-B enhanced the ability of effector populations generated to produce IL-2 and caused them to down-regulate CD45RB, an isoform of the intracytoplasmic CD45 phosphatase expressed on activated effectors but not on resting memory cells (26) . Effectors generated in the presence of TGF-~/also grew better in IL-2-containing medium than did those ceils that were never exposed to TGF-B. In studies of CD8 cells, similar effects of TGF-B were noted (27) . The effects of TGF-~/did not appear to be mediated in this instance via a shift in production of the cytokines Ib2, IFN-3,, IL-4, and Ib5, commonly used to subdivide Thl and Th2 effectors (Fig. 7) . Of course, we cannot rule out an indirect effect via untested cytokines.
TGF-~/alone partially blocked apoptosis of effectors and synergized with IL-2 to almost completely block apoptosis (Figs. 2 and 3) . TGF-~/alone modestly increased effector cell recovery, but, in contrast to II~2, it did not act as a direct proliferation factor for unstimulated effectors (Figs. 1 and 4) . This supports the hypothesis that TGF-~ acts to block apoptosis via a different pathway from IL-2. Prolonged protection from apoptosis required Ib2. The relevance of the antiapoptotic effects is seen in the fact that, when both IL2 and TGF-~/ were added, effectors were able to undergo multiple rounds of expansion, yielding populations 10,000-100,000-fold the size of the naive ceU population (Fig. 8) . Substantial growth also occurred in non-Ag-restimulated cultures, but total expansion was less and expansion was evident for a shorter time. These observations identify for the first time a set of factors-Ag, IL-2, and TGF-B-that can work together to promote extensive expansion of an effector population in vitro, without the period of massive death or "crisis" that usually accompanies the development of Ag-specific cell lines and clones.
The mechanism(s) of the TGF-B and II~2 actions are not yet dear. Since effectors die in the absence of further stimulation, it seems likely that many of the components of the apoptotic pathway are already present and/or are constitutively produced, and that the action of TGF-~/and perhaps Ib2 might include synthesis of products that block those components. Preliminary studies showed that Bcl-2, a protein implicated in blocking programmed death (1, 2) , is found at reduced levels in Ag-stimulated effectors, and that treatment of effectors with either TGF-~ or Ib2 led to increased maintenance of Bcl-2 levels (Zhang, X., L. Giangreco, H. E. Broome, and S. L. Swain, unpublished observations). We are currently studying in more detail the effects of Ag and cytokines on Bcl-2 and its family members to try to pinpoint how each cytokine may be functioning. Other aspects of the mechanism of apoptosis and its suppression, including the potential role of the Fas pathway, are also being investigated.
We suggest that the effector phase of a T cell response is an important checkpoint at which very different outcomes are possible. The potential impact of the different effector cell fates on in vivo immune response is great. Extrapolating from the in vitro studies, we would predict that the effector phase of a specific response can be either quite small and very short if Ag is rapidly cleared or if Ag is present but has failed to generate local cytokine levels of sufficient magnitude. On the other hand, if Ag levels continue to be high and a vigorous CD4 response including production of cytokines such as TGF-B and IL-2 occurs, effectors could continue to expand and function. It is likely that other factors that also regulate these decisions will be found, and it can be predicted that these might include not only other cytokines but also signals delivered by various costimulatory pathways during interaction of T cells with APC. Since many pathogens replicate rapidly, this would seem to be a useful mechanism to ensure that effector populations sufficiently large to effectively control the pathogen would be generated. Moreover, it might prove feasible to design forms of immune intervention at the time of effector response to a pathogen or after vaccination and to develop strategies either to exhaust unwanted responses or to enhance those that are desired.
